Scancell Holdings Share Price | |
---|---|
Price | 10.10 |
Bid | 9.70 |
Ask | 10.50 |
Change | 0.00 (0.00%) |
Volume | 631,989 |
Open | 10.10 |
High | 10.10 |
Low | 10.10 |
Prev. Close | 10.10 |
Currency | GBX |
---|---|
Issue Country | GB |
Shares in Issue | 928.98m |
Market Capitalisation | £93.83m |
Market Size | 30,000 |
52 Week High | 17.375 |
52 Week High Date | 20-Sep-2023 |
52 Week Low | 7.65 |
52 Week Low Date | 05-Sep-2023 |
# Trades | 16 |
---|---|
Vol. Sold | 77,066 |
Sold Value | £7.72k |
Vol. Bought | 54,923 |
Bought Value | £5.66k |
PE Ratio | -6.736028 |
Earnings | -1.4994 |
Dividend | 0.00 |
Yield | 0.00% |
Date | Time | Trade Prc | Volume | Buy/Sell | Bid | Ask | Value | |
---|---|---|---|---|---|---|---|---|
24-May-24 | 16:43:55 | 10.00 | 500,000 | Unknown* | 9.70 | 10.50 | 50.00k | O Ordinary Delayed publication |
24-May-24 | 16:27:32 | 10.325 | 20,000 | Buy* | 9.70 | 10.50 | 2,065 | O Ordinary |
24-May-24 | 15:26:46 | 10.33 | 12,100 | Buy* | 9.70 | 10.50 | 1,250 | O Ordinary |
24-May-24 | 15:16:59 | 10.33 | 6,205 | Buy* | 9.70 | 10.50 | 640.98 | O Ordinary |
24-May-24 | 14:53:23 | 9.70 | 511 | Sell* | 9.70 | 10.50 | 49.57 | O Ordinary Trade was executed as an SI |
24-May-24 | 14:53:23 | 9.70 | 204 | Sell* | 9.70 | 10.50 | 19.79 | O Ordinary Trade was executed as an SI |
24-May-24 | 14:53:23 | 9.70 | 20 | Sell* | 9.70 | 10.50 | 1.94 | O Ordinary Trade was executed as an SI |
24-May-24 | 14:53:23 | 9.70 | 416 | Sell* | 9.70 | 10.50 | 40.35 | O Ordinary Trade was executed as an SI |
24-May-24 | 14:53:23 | 10.50 | 95 | Buy* | 9.70 | 10.50 | 9.98 | O Ordinary Trade was executed as an SI |
24-May-24 | 11:54:46 | 9.92 | 11,200 | Sell* | 9.70 | 10.50 | 1,111 | O Ordinary |
Announced | Traded | Action | Notifier | Price | Currency | Amount | Holding |
---|---|---|---|---|---|---|---|
06-Dec-23 | 05-Dec-23 | Buy | Lindy Durrant held the position of CEO at the time of this trade.Lindy Durrant | 11.00 | GBX | 272,727 | 272,727 |
06-Dec-23 | 05-Dec-23 | Buy | Jean-Michel Cosséry held the position of Non-Executive Chairman at the time of this trade.Jean-Michel Cosséry | 11.00 | GBX | 454,545 | 454,545 |
03-Mar-22 | 02-Mar-22 | Buy | Martin Diggle held the position of Non-Executive Director at the time of this trade.Martin Diggle | 12.00 | GBX | 250,000 | 117,729,029 |
03-Nov-21 | 02-Nov-21 | Buy | Martin Diggle held the position of Non-Executive Director at the time of this trade.Martin Diggle | 19.00 | GBX | 200,000 | 118,479,029 |
02-Nov-21 | 29-Oct-21 | Buy | Martin Diggle held the position of Non-Executive Director at the time of this trade.Martin Diggle | 19.00 | GBX | 100,000 | 118,279,029 |
Scancell is focused on developing innovative immunotherapies for cancer that stimulate the body’s own immune system.